01-30-2012 04:48 AM CET - Health & Medicine
Print PDF Email

Indian Medicine

Press release from: Dr.JRK's Siddha Research and Pharmaceuticals Pvt Ltd
(openPR) - Dr.JRK's Siddha Research and Pharma is the herbal medicine in India, and has been in the business of good manufacturing practices. We strongly believing in intellectual asset creation through discovery, documentation and development of Indian systems of medicine. G7 capsules is the solution for Allergic Disorders the herbal medicine in Inida. Atopy or hyper sensitivity is the major problem in all countries, the problem manifest in multifold ways such as primary allergic reactions, Utricaria, Scalds Utricaria, Eczema and Generalized or Local itching. Patho-physiologically, the condition develops due to abnormal levels in the IgE in the system.

For more details, please visit us,
www.jrksiddha.com

Dr. JRK's Siddha Research, Indian medicine and Pharmaceuticals commitment to research and good manufacturing practices. Good manufacturing practice, GMP are practices and the systems required to be adapted in siddha treatment pharmaceutical manufacturing, quality system covering the manufacture and testing of pharmaceuticals.

11 Perumal Koil Street,
Kunrathur,
Chennai, India.
News-ID: 208807
del.icio.us:Indian Medicine - Pressreleases - openPR - Health & Medicine MisterWong:Indian Medicine - Pressreleases - openPR - Health & Medicine Digg:Indian Medicine - Pressreleases - openPR - Health & Medicine StumbleUpon:Indian Medicine - Pressreleases - openPR - Health & Medicine Technorati:Indian Medicine - Pressreleases - openPR - Health & Medicine Reddit:Indian Medicine - Pressreleases - openPR - Health & Medicine Furl:Indian Medicine - Pressreleases - openPR - Health & Medicine WebNews:Indian Medicine - Pressreleases - openPR - Health & Medicine OneView:Indian Medicine - Pressreleases - openPR - Health & Medicine LinkArena:Indian Medicine - Pressreleases - openPR - Health & Medicine YiGG:Indian Medicine - Pressreleases - openPR - Health & Medicine
More releases More releases
Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR.
openPR disclaims liability for any content contained in this release.